3,4-methylenedioxyamphetamine has been researched along with isomethyleugenol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, AK; Chu, T; DiStefano, EW; Kumagai, Y | 1 |
| Kamata, HT; Kamata, T; Katagi, M; Miki, A; Mori, Y; Shima, N; Tsuchihashi, H; Zaitsu, K | 1 |
| Maurer, HH; Meyer, MR | 1 |
3 other study(ies) available for 3,4-methylenedioxyamphetamine and isomethyleugenol
| Article | Year |
|---|---|
Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Dose-Response Relationship, Drug; Female; Hallucinogens; Male; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Serotonin; Sex Factors; Species Specificity; Stereoisomerism | 1996 |
Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine.
Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Hydrolysis; Methylation | 2009 |
Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.
Topics: 3,4-Methylenedioxyamphetamine; Biocatalysis; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Cytochrome P-450 Enzyme System; Designer Drugs; Dopamine; Enzyme Inhibitors; Gas Chromatography-Mass Spectrometry; Humans; Kinetics; Methylation; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Stereoisomerism | 2009 |